ACEi and ARBS in Hypertension and Heart Failure
https://libcat.nshealth.ca/en/permalink/provcat39106
Pasquale Perrone Filardi, editor.
--Cham:
Springer International Publishing : Imprint: Springer ; ISCP
, c2015.
- Available Online
- View e-Book
- Location
- Online
This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewi…
- Available Online
- View e-Book
- Other Authors
- Perrone Filardi, Pasquale
- Other Authors
- International Society of Cardiovascular Pharmacotherapy
- Responsibility
- Pasquale Perrone Filardi, editor
- Alternate Title
- Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in hypertension and heart failure
- Place of Publication
- Cham
- Publisher
- Springer International Publishing : Imprint: Springer ; ISCP
- Date of Publication
- c2015
- Physical Description
- 1 online resource (x, 150 p. : 19 illus., 13 illus. in color)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9783319097886
- 9783319097879 (print ed.)
- Subjects (MeSH)
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin-Converting Enzyme Inhibitors - pharmacology
- Heart Failure - drug therapy
- Hypertension - drug therapy
- Renin-Angiotensin System
- Abstract
- This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewing the evidence and providing a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.
- Contents
- 1. Angiotensin Converting Enzyme Inhibitors and AT1 Antagonists for Treatment of Hypertension -- 2. ACE Inhibitor and Renin–Angiotensin System the Cornerstone of Therapy for Systolic Heart Failure -- 3. Impact of Chronic Kidney Disease and Diabetes Mellitus on Choice of Renin Angiotensin System: Inhibitors in Patients with Hypertension and Heart Failure -- 4. Target Organ Damage and RAAS Blockade.
- Format
- e-Book
- Location
- Online
Antiplatelet and anticoagulation therapy
https://libcat.nshealth.ca/en/permalink/provcat32336
Albert Ferro, David A. Garcia, editors.
--London:
Springer
, c2013.
- Available Online
- View e-Book
- Location
- Online
Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements in the treatment and prevention of arterial thrombotic disease. In the field of anticoagulation, the vitamin K antagonists such as warfarin have not been available for as long as aspirin in the antip…
- Available Online
- View e-Book
- Other Authors
- Ferro, Albert
- Garcia, David A
- Responsibility
- Albert Ferro, David A. Garcia, editors
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2013
- Physical Description
- 1 online resource (x, 247 p. : 37 ill., 26 ill. in color)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9781447142973
- Subjects (MeSH)
- Arterial Occlusive Diseases - drug therapy
- Blood Coagulation Factor Inhibitors - therapeutic use
- Platelet Aggregation Inhibitors - therapeutic use
- Thrombosis - drug therapy
- Subjects (LCSH)
- Cardiology
- Abstract
- Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements in the treatment and prevention of arterial thrombotic disease. In the field of anticoagulation, the vitamin K antagonists such as warfarin have not been available for as long as aspirin in the antiplatelet field, and have also had very little in the way of competition until recently; although a number of parenteral anticoagulants have been available, the vitamin K antagonists have been the only orally active anticoagulant drugs. The last few years have seen the arrival of new drug classes, the orally active direct thrombin inhibitors and factor Xa antagonists, which offer a number of advantages, but not without important drawbacks. In the face of these important advances in both antiplatelet and anticoagulant therapy, clinicians often feel confused, even overwhelmed, as to what is now available and which drugs are useful (and indicated) in which circumstances. Antiplatelet and Anticoagulant Therapy is designed with such people in mind. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.
- Contents
- Antiplatelet agents: current and novel -- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring -- Anticoagulant Drugs: Current and Novel -- Antithrombotic Treatment of Cardiovascular Disease -- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease -- Index.
- Format
- e-Book
- Location
- Online
Pharmacological Treatment of Chronic Stable Angina Pectoris
https://libcat.nshealth.ca/en/permalink/provcat39277
Pablo Avanzas, Juan Carlos Kaski, editors.
--Cham:
Springer
, c2015.
- Available Online
- View e-Book
- Location
- Online
This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals inclu…
- Available Online
- View e-Book
- Other Authors
- Avanzas, Pablo
- Kaski, Juan Carlos
- Responsibility
- Pablo Avanzas, Juan Carlos Kaski, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2015
- Physical Description
- 1 online resource (xi, 278 p. : 32 illus., 23 illus. in color)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9783319173320
- 9783319173313 (print ed.)
- Subjects (MeSH)
- Adrenergic beta-Antagonists - therapeutic use
- Angina Pectoris - drug therapy
- Cardiovascular Agents - therapeutic use
- Abstract
- This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guide the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.
- Contents
- Mechanisms of angina pectoris -- An overview of treatment and guidelines: ESC/ACC-AHA/NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine -- Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.
- Format
- e-Book
- Location
- Online
